You are viewing: Europe Pet Biotics Market analysis
Part of: Pet Biotics Market (Global)

The Europe Pet Biotics Market was valued at $257.1 Million in 2025 and projected to reach to $353.1 Million by 2030, representing a compound annual growth rate of 6.6%. Europe's pet biotics market is positioned for sustained expansion through 2030, supported by rising pet ownership rates, increasing veterinary recommendations, and growing consumer education on digestive health benefits.

Europe Pet Biotics Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe Pet Biotics Market Trends and Insights

  • This growth trajectory reflects Europe's strong consumer awareness of pet health and wellness, where probiotics and digestive supplements have become mainstream pet care categories.
  • Europe leads in premium pet nutrition adoption, with pet owners increasingly seeking science-backed solutions to improve their animals' gut health and overall immunity. The European market benefits from stringent regulatory frameworks and high consumer trust in certified pet health products.
  • Europe's forecast period (2025–2030) will be shaped by rising pet ownership, growing veterinary recommendations for preventive care, and expanding distribution through both e-commerce and specialty pet retailers.
  • The region's mature pet care infrastructure and disposable income levels position Europe as a key driver of global pet biotics innovation and market expansion..

Key Market Statistics

  • CAGR (2025-2030) 6.6% CAGR
  • Market Size, 2025 ~USD 257.1 Million
  • Forecast, 2030 ~USD 353.1 Million
  • Geography Europe

Europe Pet Biotics Market Overview

Market Valuation & Growth :

Europe's pet biotics market is valued at USD 257.1 million in 2025, with a projected CAGR of 6.6% through 2030, reaching USD 353.1 million. This steady growth outpaces many mature markets, driven by strong consumer investment in pet wellness.

Premium Pet Nutrition Leadership :

European pet owners lead globally in premium nutrition adoption, with probiotics and digestive supplements now mainstream categories. Germany, UK, and France represent the largest markets, reflecting high disposable income and pet health consciousness.

Consumer Health Awareness :

Europe demonstrates exceptional consumer awareness of pet health and wellness trends. Pet owners increasingly view probiotics as essential preventative care, mirroring human health supplement adoption patterns across the continent.

Regional Market Concentration :

Germany leads European market share at USD 93.4 million, followed by UK (USD 80.9 million) and France (USD 56.4 million). These three countries represent over 70% of Europe's total pet biotics market value.

Europe Pet Biotics Market Dynamics

  • The region's mature pet care infrastructure and premium product positioning create favorable conditions for innovation in probiotic formulations and delivery mechanisms. Key growth drivers include regulatory support for pet supplements, expansion of e-commerce distribution channels, and collaboration between pet food manufacturers and probiotic specialists.
  • European pet owners' willingness to invest in preventative health solutions ensures continued market resilience, with particular opportunities in functional treats and tailored breed-specific formulations..

Related Ecosystem

Fandb Additives

Top Technologies
  • Dairy Products
  • Bakery Products
  • Polyglycerol Esters
  • Microorganism
  • Carbohydrates
Top Companies
  • AZELIS HOLDINGS SA
  • Archer-Daniels-Midland Company
  • Amway
  • UNILEVER PLC
  • DuPont de Nemours, Inc.

    Key Takeaways

    • Europe's pet biotics market is valued at USD 257.1 million in 2025 and will grow to USD 353.1 million by 2030, representing a 6.6% CAGR.
    • Europe leads in premium pet nutrition, with consumers prioritizing preventive health and science-backed probiotic solutions for their pets.
    • Stringent EU regulatory standards and high consumer trust drive adoption of certified pet biotics across Europe.
    • E-commerce and veterinary channels are expanding distribution, supporting Europe's market growth through 2030.

    Pet Biotics Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment ORAL & DENTAL HEALTH (Function)
    Forecast Period 2025–2030
    Growth Rate CAGR of 6.9% from 2025 to 2030
    Largest Segment DRY (Form)
    Market Size Base Year (Billions) ~USD 0.88 (2025)
    Revenue Forecast (Billions) ~USD 1.23 (2030)
    Segments Covered Type, Subtype, Application, Form, Pet, Function

    Europe Pet Biotics Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Type

    • Bacteria
    • Bifidobacterium
    • Fos
    • Gos
    • Inulin
    • Lactobacillus
    • Mos
    • Oligosaccharides
    • Other Bacteria
    • Other Prebiotic Types
    • Polydextrose
    • Postbiotics
    • Prebiotics
    • Probiotics
    • Saccharomyces Boulardii
    • Saccharomyces Cerevisiae
    • Yeast & Fungi

    By Subtype

    • Bacillus
    • Bifidobacterium
    • Enterococcus
    • Lactobacillus
    • Streptococcus Thermophilus

    By Application

    • Dry Food
    • Snacks & Treats
    • Supplements
    • Wet Food

    By Form

    • Dry
    • Liquid

    By Pet

    • Cats
    • Dogs
    • Other Pets

    By Function

    • Digestive/Gut Health
    • Immune Modulation
    • Metabolic & Weight Management
    • Oral & Dental Health
    • Other Functions

    EUROPE: PET BIOTICS MARKET, BY APPLICATION, 2025–2030

    Segment202520262027202820292030CAGR (%)
    DRY FOOD122.3129.5137.3145.9155.3165.66.3
    SNACKS & TREATS35.437.640.142.745.748.96.7
    SUPPLEMENTS73.17883.489.395.81037.1
    WET FOOD26.327.829.531.333.335.56.2
    TOTAL257.1272.9290.2309.2330.1353.16.6

    Target Audience

    • Pet Nutrition Manufacturers : Develop and launch pet biotic products tailored to European consumer preferences. Understand market sizing, competitive positioning, and growth opportunities across premium pet nutrition segments to maximize market penetration.
    • Probiotic & Supplement Producers : Identify expansion opportunities in Europe's high-value pet biotics segment. Access market data to guide product formulation, pricing strategy, and distribution partnerships with European pet retailers and veterinary channels.
    • Pet Food Retailers & Distributors : Optimize product portfolio and shelf allocation decisions with market size data by country. Understand consumer demand patterns and growth forecasts to negotiate supplier terms and plan inventory management effectively.
    • Veterinary & Pet Health Professionals : Stay informed on market trends, product innovations, and consumer adoption of pet probiotics. Use market intelligence to guide clinical recommendations and identify emerging therapeutic opportunities in digestive health.
    • Investment & Private Equity Firms : Evaluate investment opportunities in Europe's growing pet biotics sector. Assess market attractiveness, growth potential, and competitive dynamics to identify acquisition targets and portfolio companies with strong regional positioning.

    Key Companies in the Europe Pet Biotics Market

    CompanyHQOwnershipStrongest segments
    ADMUnited StatesPublic CompanyAg Services and Oilseeds,Carbohydrate Solutions,Nutrition,
    KERRY GROUP PLCIrelandPublic CompanyTaste solutions (flavours, extracts, modulations),Nutrition solutions (enzymes, proteins, lipids, fibre, wellness),Functional ingredients, food and beverage solutions,
    DSM-FIRMENICHSwitzerlandPublic CompanyPerfumery & Beauty,Taste, Texture & Health,Health, Nutrition & Care,
    CARGILL, INCORPORATEDUnited StatesPrivate CompanyGrains & Oilseeds Origination, Trading, and Processing,Animal Nutrition & Protein (Livestock, Aquaculture, Meat, Poultry),Food & Beverage Ingredients and Foodservice/Retail Solutions,
    PROBISwedenPrivate CompanyDietary supplement probiotics (capsules, tablets, chewables, powders),Food and beverage probiotics (drinks, shots, carbonated, dairy, plant-based, frozen desserts),Specialized formulations (children’s, oral, bone, iron-absorption, recovery drinks, powder formulas),
    PHILEO BY LESAFFREFranceSubsidiaryYeast-based functional additives (MOS, ß-glucans, yeast cell walls, inactivated yeasts),Probiotics, live bacteria, and direct-fed microbials,Postbiotics and fermentation-derived metabolites,

    ADM

    ADM (Archer Daniels Midland Company) is a publicly traded American agricultural processor and food ingredient company founded in 1902. With 41,147 employees, ADM operates globally in grain processing, oilseed crushing, and ingredient manufacturing.

    KERRY GROUP PLC

    Kerry Group PLC is a publicly traded Irish food and beverage ingredients company founded in 1972. With 19,284 employees, the company specializes in taste and nutrition solutions for the food industry.

    DSM-FIRMENICH

    DSM-Firmenich is a publicly traded Swiss company founded in 1902 with 26,873 employees, specializing in nutrition, health, and beauty ingredients. The company serves the food, beverage, dietary supplement, and personal care industries.

    CARGILL, INCORPORATED

    Cargill, Incorporated is a privately held American agricultural and food processing company founded in 1865. With 155,000 employees, Cargill is one of the world's largest privately held corporations, operating in grain trading, livestock, and food ingredient production.

    PROBI

    Probi is a Swedish private company founded in 1991 with 157 employees, specializing in probiotic products and dietary supplements. The company focuses on developing and commercializing probiotic-based health solutions.

    PHILEO BY LESAFFRE

    Phileo by Lesaffre is a subsidiary company founded in France in 2011, specializing in microbial solutions and probiotics for animal nutrition and health.

    Europe vs. other regions

    HowEurope compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 485.6 Million · 6.9% wtd CAGR ·
    Asia Pacific
    ~USD 278.7 Million · 8% wtd CAGR ·

    Countries within Europe - compare and drill down

    Country2025 size (native)
    GermanyUSD 93.4 Million
    UKUSD 80.9 Million
    FranceUSD 56.4 Million
    ItalyUSD 40.5 Million
    SpainUSD 22 Million

    Country market size visualization

    Germany
    USD 93.4 Million
    UK
    USD 80.9 Million
    France
    USD 56.4 Million
    Italy
    USD 40.5 Million
    Spain
    USD 22 Million

    Reasons to Buy this Report

    • Market Size & Forecast Data : Access precise valuation metrics for Europe's pet biotics market with country-level breakdowns. Understand market trajectory from USD 257.1M (2025) to USD 353.1M (2030) to inform strategic planning and investment decisions.
    • Competitive Landscape Intelligence : Identify leading markets and regional opportunities across Germany, UK, France, Italy, and Spain. Benchmark performance metrics and understand market concentration patterns to optimize market entry and expansion strategies.
    • Consumer Behavior Insights : Gain deep understanding of European pet owner preferences for premium nutrition, probiotics adoption rates, and willingness to invest in pet wellness. Leverage consumer health consciousness trends to develop targeted marketing campaigns.
    • Growth Driver Analysis : Understand region-specific factors driving 6.6% CAGR including regulatory environment, distribution channels, veterinary partnerships, and e-commerce expansion. Identify untapped opportunities in emerging European markets.
    • Strategic Decision Support : Make informed decisions on product development, market positioning, and resource allocation with comprehensive Europe-focused market intelligence. Reduce investment risk through data-driven insights on regional dynamics and consumer trends.

    Frequently asked questions

    What is the current size of Europe's pet biotics market?

    Europe's pet biotics market is valued at USD 257.1 million in 2025 and is expected to reach USD 353.1 million by 2030.

    What is the growth rate for pet biotics in Europe?

    Europe's pet biotics market is growing at a compound annual growth rate (CAGR) of 6.6% from 2025 to 2030.

    Why is Europe a key market for pet biotics?

    Europe has high pet ownership rates, strong consumer awareness of pet health, stringent regulatory standards, and significant disposable income, making it a premium market for pet biotics.

    Which distribution channels are driving growth in Europe's pet biotics market?

    E-commerce platforms, specialty pet retailers, and veterinary clinics are the primary distribution channels expanding Europe's pet biotics market through 2030.

    What regulatory factors influence Europe's pet biotics market?

    Europe's stringent EU regulatory frameworks for pet food and supplements ensure product safety and quality, building consumer trust and supporting market growth.

    RESEARCH METHODOLOGY

    This study employed two primary approaches to estimate the current size of the pet biotics market. Exhaustive secondary research was conducted to gather information on the type, application, pet, form, function, and manufacturing technology segments of the market (qualitative). The next step involved validating these findings, assumptions, and sizing with industry experts across the value chain through primary research. The top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, data triangulation was used to estimate the market size of segments and subsegments.

    Secondary Research

    This research study utilized extensive secondary sources, including directories and databases such as Bloomberg Businessweek and Factiva, to identify and collect information for a technical, market-oriented, and commercial market study. In the secondary research process, sources such as annual reports, press releases & investor presentations of companies, white papers, pet food journals, certified publications, articles from recognized authors, directories, and databases were referred to identify and collect information. Secondary research was mainly used to obtain key information about the industry’s supply chain, the pool of key players, and market classification and segmentation based on the industry trends to the bottom-most level, regional markets, and key developments from market- and technology-oriented perspectives.

    Primary Research

    Extensive primary research was conducted after obtaining information regarding the pet biotics market scenario through secondary research. Several primary interviews were conducted with market experts from the demand and supply sides across major countries of North America, Europe, Asia Pacific, South America, and the Rest of the World. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief Experience Officers (CXOs), vice presidents (VPs), directors from business development, marketing, research, and development teams, as well as key executives from distributors and key opinion leaders.

    Primary interviews were conducted to gather insights, including market statistics, revenue data from products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped to understand the various trends related to type, application, pet, form, functions, and manufacturing technology (qualitative), as well as region. Stakeholders from the demand side, including distributors, importers, exporters, and end-use sectors such as pet food and pet supplement manufacturers, were interviewed to gain insight into the buyers’ perspective on suppliers, products, and the outlook for their businesses, which will impact the overall market.

    Pet Biotics Market
 Size, and Share

    The three tiers of the companies are defined based on their total revenues in 2023 or 2024, based on the availability of financial data: Tier 1: Revenue > USD 1 billion; Tier 2: USD 100 million ≤ revenue ≤ USD 1 billion; Tier 3: Revenue < USD 100 million.

    RoW includes Africa and the Middle East.

    COMPANY NAME

    DESIGNATION

    Cargill, Incorporated (US)

    Product Development Manager

    Bharat International Pet Foods Pvt. Ltd. (Manager)

    Sales Manager

    Purina Animal Nutrition LLC (US)

    Marketing Head

    BIOPROX (France)

    Marketing Head

    Alltech (US)

    Senior Sales Manager

    Kemin Industries, Inc. (US)

    Business Development Manager

     

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The top-down and bottom-up approaches were used to estimate and validate the total size of the pet biotics market. These approaches were also used extensively to determine the size of various market segments. The research methodology used to estimate the market size includes the following details:

    • The key players in the industry and the overall markets were identified through extensive secondary research.
    • All shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
    • All possible parameters that affect the market covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain final quantitative and qualitative data.
    • The research included the study of reports, reviews, and newsletters of top market players, along with extensive interviews for opinions from leaders, such as CEOs, directors, and marketing executives.

    Pet Biotics Market : Top-Down and Bottom-Up Approach

    Pet Biotics Market  Top Down and Bottom Up Approach

    Data Triangulation

    After determining the overall market size from the estimation process explained above, the total market was split into several segments and subsegments. The data triangulation procedure was employed, wherever applicable, to estimate the overall pet biotics market and obtain precise statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. The market size was also validated using the top-down and bottom-up approaches.

    Market Definition

    Pet biotics refer to a group of functional ingredients, including probiotics, prebiotics, and postbiotics, that are incorporated into pet foods, treats, toppers, and nutritional supplements to support gut health, digestion, immunity, nutrient absorption, and overall well-being. Probiotics are live beneficial microorganisms, prebiotics are non-digestible fibers that selectively nourish these beneficial microbes, and postbiotics are bioactive compounds produced through microbial fermentation. Together, these ingredients help maintain a balanced gut microbiome and enhance the health and performance of pets.

    Key Stakeholders

    • Probiotic strain manufacturers
    • Prebiotics & postbiotics ingredient manufacturers
    • Pet food and supplement product manufacturers
    • Key companies engaged in pet food processing
    • Intermediate stakeholders, including distributors, retailers, associations, regulatory bodies, and others
    • Government organizations, institutes, and research organizations
    • Associations and industry bodies:
      • Pet Food Institute (PFI)
      • International Probiotics Association (IPA)
      • International Scientific Association for Probiotics and Prebiotics (ISAPP)
      • European Food Safety Authority (EFSA)
      • American Pet Products Association
      • Global Alliance of Pet Food Associations
      • The European Pet Organization
      • Association of American Feed Control Officials (AAFCO)
      • American Veterinary Medical Association (AVMA)

    Report Objectives

    • To determine and project the size of the pet biotics market based on type, application, pet, form, function, manufacturing technology (qualitative), and region, over five years, ranging from 2025 to 2030
    • To identify the attractive opportunities in the market by determining the largest and fastest-growing segments across regions
    • To provide detailed information about the key factors influencing market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To analyze the micromarkets with respect to individual growth trends, prospects, and their contribution to the total market
    • To identify and profile the key players in the market
    • To understand the competitive landscape and identify the major growth strategies adopted by players across the key regions

    Customization Options

    With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs. The following customization options are available for the report:

    Product Analysis

    • Product matrix, which provides a detailed comparison of each company's product portfolio.

    Geographic Analysis

    With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

    • Further breakdown of the Rest of European pet biotics market into key countries
    • Further breakdown of the Rest of Asia Pacific pet biotics market into key countries
    • Further breakdown of the Rest of South American pet biotics market into key countries

    Company Information

    • Detailed analyses and profiling of additional market players (up to five)

     

     

    Get the Full Pet Biotics Market Report

    Full forecast, segment splits, and company analysis for all Pet Biotics Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status